Heterogeneity of recombinant antibodies: Linking structure to function

Developments in Biologicals

Volumn 122, Issue , 2005, Pages 117-127

  Harris, R J ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; OMALIZUMAB; TRASTUZUMAB;

ANIMAL; CHEMISTRY; CONFERENCE PAPER; HUMAN; PROTEIN PROCESSING; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; HUMANS; IMMUNOGLOBULIN G; PROTEIN MODIFICATION, TRANSLATIONAL; PROTEIN PROCESSING, POST-TRANSLATIONAL; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33644619972     PISSN: 14246074     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (14)

1. Jefferis R, Lund J: Interaction sites on human IgG Fc for FcγR: current models. Immunol Lett 2002;82:57-65.
2. Harris RJ: The processing of C-terminal Lys and Arg residues of proteins isolated from mammalian cell culture. J Chromatogr. A 1995;705:129-134.
3. Shen FJ, Kwong MY, Keck RG, Harris RJ: The application of tert-butylhydroperoxide oxidation to study sites of potential methionine oxidation in a recombinant antibody, in Marshak D (ed): Techniques in Protein Chemistry. San Diego, Academic Press, 1996, vol 7, pp 275-284.
4. 1 N-linked oligosaccharide improves binding to human FcγRIII and antibody-dependent cellular toxicity. J Biol Chem 2002;277:26733-26740.
5. Shinkawa T, Nakamara K, Yamane N, Shoji-Hosaka E, Kanda Y, Sakurada M, Uchida K, Anazawa H, Satoh M, Yamasaki M, Hanai N, Shitara K: The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J Biol Chem 2003;278:3466-3473.
6. Catron G, Dacheux L, Salles G, Solal-Geligny P, Bardos P, Colombat P, Watier H: Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene. Blood 2002;99:754-758.
7. Junghans RP, Anderson CL: The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor. Proc Natl Acad Sci USA 1996;93:5512-5516.
8. Weitzhandler M, Farnan D, Rohrer JS, Avdalovic N: Protein variant separations using cation exchange chromatography on grafted, polymeric stationary phases. Proteomics 2001;1:179-185.
9. Kroon DJ, Balwin-Ferro A, Lalan P: Identification of sites of degradation in a therapeutic monoclonal antibody by peptide mapping. Pharm Res 1992;9:1386-1393.
10. Geiger T, Clarke S: Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in proteins. J Biol Chem 1987;262:785-794.
11. Harris RJ, Kabakoff B, Macchi FD, Shen FJ, Kwong M, Andya J, Shire SJ, Bjork N, Totpal K, Chen AB: Identification of Multiple Sources of Charge Heterogeneity in a Recombinant Antibody. J Chromatogr B 2001;752:233-245.
12. Kwong MY, Harris RJ: Identification of protein succinimides by N-terminal sequence analysis after alkaline hydroxylamine cleavage. Protein Sci 1994;3,147-149.
13. Cacia J, Keck R, Presta LG, Frenz J: Isomerization of an aspartic acid residue in the complementarity-determining regions of a recombinant antibody to human IgE: identification and effect on binding affinity. Biochemistry1996;35: 1897-1903.
14. Edelman GM, Cunningham BA, Gall WE, Gottleib PD, Rutishauser U, Waxdal MJ: The covalent structure of an entire γG immunoglobulin molecule. Proc Natl Acad Sci USA 1969;63:78-85.